Kyverna Therapeutics, Inc.
Biotechnology company · Emeryville, California, United States · Nasdaq: KYTX
Kyverna Therapeutics, Inc. is a biotechnology company headquartered in Emeryville, California, United States. Its shares trade on Nasdaq under the ticker KYTX. It has reported private securities offerings to the US SEC, most recently $152 million sold in a notice filed in 2023.
Kyverna Therapeutics at a glance
What does Kyverna Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $152 million sold (2023).
Frequently asked questions about Kyverna Therapeutics
Where is Kyverna Therapeutics headquartered?
Kyverna Therapeutics, Inc. is headquartered in Emeryville, California, United States.
What does Kyverna Therapeutics do?
Kyverna Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Kyverna Therapeutics a public company?
Yes. Kyverna Therapeutics, Inc. trades on Nasdaq under the ticker KYTX.
Similar companies
- 4D Molecular Therapeutics, Inc.Emeryville, California, United States
- Gritstone bio, Inc.Emeryville, California, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.